RejuvenAir
Developer of an interventional device designed to offer the therapy of chronic obstructive pulmonary disease with chronic bronchitis using metered cryospray. The company's device incorporates software...
Valuation
$156M
Market implied
Share Price
N/A
Total Raised
$191.4M
Last Round
N/A